ANZGOG has awarded four Fund for New Research (FFNR) grants for 2023. This year’s grant round received 18 applications, each aligned with ANZGOG’s research program areas of focus.
Grants were awarded to:
$32,569 Ovarian Project: PI A/Prof Kylie Gorringe -Testing anti-HER2 antibody drug conjugate in mucinous ovarian cancer models.
$42,143 Uterine Project: PI A/Prof Emma Allanson –The feasibility and acceptability of patient initiated follow up following surgical management of low-risk endometrial endometrioid adenocarcinoma.
$50,000 Gynae (incl. Cervical/Vulval/Vaginal) Project: PI Dr Marilyn Boo – Quality of life and adherence to post-operative thromboprophylaxis following surgery for gynaecological cancers: rivaroxaban vs enoxaparin – The Gynaecology Oncology RivarOXiban pilot study (GoROX pilot study).
$50,000 Survivorship/QOL Project: PI A/Prof Alison Davis – The time toxicity involved in medical treatment for Platinum resistant or refractory Ovarian Cancer (PRROC).
Each application was reviewed by the Fund for New Research Grant Panel and scored against either a clinical/translational or pre-clinical study set of criteria. The ANZGOG Board reviewed and ratified the recommended priority projects thereafter.
Want to know more about ANZGOG’s Fund for New Research program?
“The Fund for New Research program, supported by public donations, is ideally suited to foster innovative pre-clinical and pilot clinical trials in gynaecological cancers. This project is an excellent example of donor and researcher collaboration.”
ANZGOG Chair, Prof. Clare Scott AM
ANZGOG’s Fund for New Research grant’s purpose is to promote the development of future clinical trials and foster its member’s research studies.
The Fund for New Research is made possible by public donations, bequests and philanthropic grants from charities with shared interests in ANZGOG’s research work.
With this support, ANZGOG has been able to support 25 studies from 2015 to 2023 inclusive. Learn more about FFNR:
